Divyaswathi Citla Sridhar: We Counsel Patients With Obesity About VTE Risk, But What Does Real-World Data Actually Show?
Divyaswathi Citla Sridhar, a pediatric hematologist and oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:
“We counsel patients with obesity about VTE risk—but what does real-world data actually show?
Our new study published in RPTH Journal analyzed >4 million females prescribed hormonal therapy and found:
• Higher VTE rates with several ethinyl-estradiol–containing therapies in obese users
• No significant VTE increase with progesterone-only therapy
Title: Venous thromboembolism in obese hormonal contraceptive users: a large national database study
Authors: Divyaswathi Citla-Sridhar, Madhvi Rajpurkar, Lakshmi Srivaths, Bethany Samuelson Bannow, Rachel P. Rosovsky, Nancy Sokkary.
Grateful to work with a fantastic group of collaborators: Madhvi Rajpurkar Lakshmi Srivaths Bethany Samuelson Bannow Rachel Rosovsky Nancy Sokkary & Foundation for Women & Girls With Blood Disorders.”
Learn more with Hemostasis Today.
-
Apr 12, 2026, 15:38Hugo Antonio Romo Rubio: ASH ISTH 2026 Guidelines on Prophylactic Anticoagulation In Pediatrics
-
Apr 12, 2026, 15:26Melissa Lewellyn: The DVT and PE Awareness Resolution from NBCA Is Now Live
-
Apr 12, 2026, 14:58Akram Shibani: HI-PEITHO Trial Reminds Us Why Composite Endpoints Deserve Careful Scrutiny
-
Apr 12, 2026, 14:493 Days, 14 Leaders, 1 Mission at The 13th EHC Youth Leadership Workshop
-
Apr 12, 2026, 14:27Moustafa Abdou: Paroxysmal Nocturnal Hemoglobinuria From a Rare Disease to a Treatable Condition
-
Apr 12, 2026, 14:18Jean Jacques Kiladjian: Grateful to the MSH for the invitation to ‘Highlights of ASH’ in Asia-Pacific 2026
-
Apr 12, 2026, 14:15Paritosh Garg: A fibrotic marrow is not always PMF
-
Apr 12, 2026, 14:13Scott Woller: ACC/AHA Guidelines and the Role of Pulmonary Embolism Response Teams
-
Apr 12, 2026, 13:55Ifeanyichukwu Ifechidere: When Fibrinogen isn’t Really Fibrinogen